News

Large granular lymphocytic leukemias (LGLLs) are a heterogeneous group of rare chronic lymphoproliferative disorders characterized by the clonal ...
Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...
A local college student is in the fight of his life, battling cancer. Lackawanna County residents are rallying around him as ...
Mid Valley High School graduate Eddie Kaufman has always been a team player, whether on the baseball field or the golf course ...
Axi-cel, tisa-cel, and brexu-cel were found comparable to other cellular therapy experiences for patients with B-cell ...
Helix BioPharma is a clinical-stage biopharmaceutical company aiming to turn scientific breakthroughs into real-world ...
An Omaha girl with a rare, high-risk form of leukemia is smiling through life against all odds, so Make-A-Wish made the ...
In March 2025, Juventas Cell Therapy Ltd. conducted a phase Ib/II trial to evaluate the safety and efficacy of CNCT19 ...
If preclinical findings were translated into the clinic, they could shorten the CAR-T generation lead time from two weeks to ...